Statin intensity, concomitant medication use, and demographic factors including ancestry, age, and sex have been associated with increased SAMS risk independent of SLCO1B1 genotype [12,76]. This evidence concerns the gene SLCO1B1 and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.